Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Infectious Disease Experts Say Diagnostics Underutilized, More Needed

This article was originally published in The Gray Sheet

Executive Summary

The Infectious Diseases Society of America released a policy paper that “raises the red flag about the paucity of new and rapid tests despite years of promises from the molecular era.” It recommends simplifying regulations and improving the reimbursement process, as well as physician education.


Related Content

CMS Director To Diagnostics Industry: Prove Your Cancer Tests Work
A “Breakthrough” Reality Check: Sponsors Seek FDA Flexibility On Manufacturing, Diagnostics





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts